A Short Seller's Skin in the Game, and Three Auditors Who Said Not Yet

DMG Mori's board resolved on August 12 to issue 15 million new shares through a public offering in Europe and Asia, excluding the US and Canada, raising roughly ¥48.5bn before costs and about ¥48.2bn after issuance expenses. The sale lifts outstanding shares from 142.3mn to 157.3mn. What the money buys: An expanded casting-parts plant in Poland, a new R&D centre in Chicago, roughly ¥10bn held in reserve for acquisitions, and redemption of the company's perpetual subordinated bonds.

Why it matters: A machine-tool maker funding a European casting expansion and a US R&D hub through overseas equity, rather than yen debt, is a bet that international investors will price the growth story more cheaply than the domestic bond market would.

A U.S. semiconductor-metrology company now holds 27% of the Tokyo-listed instrument maker after a Carlyle-linked fund's voting stake fell from 27.29% to 0.29%, while a separate asset manager crossed the 10% disclosure threshold the same week.

Two completed exits, including the sale of M&I and Toyo Engineering, generated realized carried interest that pushed Integral's half-year profit to ¥8.77bn from ¥1.70bn a year earlier, its regulatory filing shows.

Oasis Management's stake in AEON Financial Service climbed to 10.80% from 9.78%, and the fund has told regulators it may push for board removals, asset sales, delisting, or dividend policy changes within 12 months, plus a possible further 5%-plus purchase within three months if the price looks cheap.

WOWOW and NTT Docomo signed the absorption-split contract on August 12 that will fold Docomo's Lemino streaming business into a joint venture 51% owned by WOWOW, with the split, share transfer and commercial launch all targeted for October 1; WOWOW says the earnings impact for the year to March 2027 is still under review.

A tip-off about past used-truck sales has widened into a three-fiscal-year accounting correction at AI storm, forcing the company to delay its quarterly results to November and consider a statutory filing extension while its auditor withholds sign-off.

Takara Holdings pulled its August 7 earnings release after its auditor said it could not complete a quarterly review of Takara Bio USA's accounts, and the Kyoto group now expects to miss the standard 45-day disclosure deadline with no new date set.

Two Sunwels term loans, carrying balances of ¥321mn and ¥549mn, tripped their covenants this quarter, and lenders have only granted a principal repayment pause through September while the Parkinson's-care operator freezes new facility openings and absorbs a reimbursement-fee cut.